XPH, PCRX, RPRX, SLXP: Large Inflows Detected At ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Pharmaceuticals ETF ( XPH) where we have detected an approximate $46.8 million dollar inflow -- that's a 6.2% increase week over week in outstanding units (from 8,100,135 to 8,600,135). Among the largest underlying components of XPH, in trading today Pacira Pharmaceuticals Inc. ( PCRX) is off about 2.4%, Repros Therapeutics Inc ( RPRX) is down about 2.8%, and Salix Pharmaceuticals Ltd ( SLXP) is lower by about 1.3%. For a complete list of holdings, visit the XPH Holdings page »

Click here to find out which 9 other ETFs had notable inflows »

The chart below shows the one year price performance of XPH, versus its 200 day moving average:

SPDR S&P Pharmaceuticals ETF 200 Day Moving Average Chart

Looking at the chart above, XPH's low point in its 52 week range is $59.79 per share, with $94.49 as the 52 week high point — that compares with a last trade of $92.48. Comparing the most recent share price to the 200 day moving average can also be a useful technical analysis technique -- learn more about the 200 day moving average ».

Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand. Each week we monitor the week-over-week change in shares outstanding data, to keep a lookout for those ETFs experiencing notable inflows (many new units created) or outflows (many old units destroyed). Creation of new units will mean the underlying holdings of the ETF need to be purchased, while destruction of units involves selling underlying holdings, so large flows can also impact the individual components held within ETFs.

If you liked this article you might like

Stocks Fall for Day Two as Trump Targets Health Care Sector

Stocks Slide as Health Care Sector Weighs on Wall Street

Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan

Drugmakers Suffer After Trump Tweet

Stocks Fluctuate as Wall Street Digests Health Care Moves From Washington